An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07315633

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:43.430276+00:00

Published At

2026-01-02T00:00:00+00:00

Record Updated At

2026-01-02

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Hepatocellular Carcinoma (HCC)", "Liver Cancer, Adult", "Liver Cancer"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-01-02"

protocolSection.identificationModule.nctId

"NCT07315633"

protocolSection.identificationModule.officialTitle

"An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Hepatocellular Carcinoma (HCC) (protocolSection.conditionsModule.conditions)
• Liver Cancer, Adult (protocolSection.conditionsModule.conditions)
• Liver Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.